NEW YORK (GenomeWeb) – Belgian molecular diagnostics firm Biocartis announced today that it has partnered with Bristol-Myers Squibb to develop a companion diagnostic for a number of cancer immunotherapies, with an initial focus on colorectal cancer (CRC).
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.